117516-97-9 Usage
Description
2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one is a heterocyclic organic compound characterized by a thieno[2,3-d]pyrimidine ring system with a thioxo group at the 2-position. It has the molecular formula C7H5N3OS and is known for its potential pharmaceutical applications due to its unique structural features and biological activities. 2-Thioxo-2,3-
dihydrothieno[2,3-d]pyrimidin-4(1H)-one serves as a starting material in the synthesis of various drugs and bioactive compounds, and it has shown promising antitumor and antiviral properties, making it a significant compound for research and development in medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one is used as a starting material for the synthesis of various drugs and bioactive compounds. Its unique structural features and biological activities make it a valuable component in the development of new pharmaceuticals.
Used in Antitumor Applications:
2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one is used as an antitumor agent due to its promising antitumor activities. It has the potential to be further developed and optimized for use in cancer treatment, targeting various types of tumors and contributing to the advancement of oncology.
Used in Antiviral Applications:
2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one is used as an antiviral agent, exhibiting potential in the development of treatments for viral infections. Its antiviral properties make it a candidate for further research and development in the field of virology and infectious diseases.
Used in Medicinal Chemistry Research:
2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one is used as a subject of research in medicinal chemistry. Its unique structure and biological activities make it an important compound for understanding the relationship between chemical structure and biological function, as well as for the discovery of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 117516-97-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,5,1 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 117516-97:
(8*1)+(7*1)+(6*7)+(5*5)+(4*1)+(3*6)+(2*9)+(1*7)=129
129 % 10 = 9
So 117516-97-9 is a valid CAS Registry Number.
117516-97-9Relevant articles and documents
Development of matrix metalloproteinase-13 inhibitors – A structure-activity/structure-property relationship study
Fuerst, Rita,Yong Choi, Jun,Knapinska, Anna M.,Smith, Lyndsay,Cameron, Michael D.,Ruiz, Claudia,Fields, Gregg B.,Roush, William R.
, p. 4984 - 4995 (2018/09/27)
A structure-activity/structure-property relationship study based on the physicochemical as well as in vitro pharmacokinetic properties of a first generation matrix metalloproteinase (MMP)-13 inhibitor (2) was undertaken. After systematic variation of inhi
Synthesis of new 1-phenylthieno[1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one derivatives
Song, Yang-Heon,Son, Hoon Young
, p. 597 - 603 (2011/07/07)
A series of novel 1-phenylthieno[1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one derivatives 5 and 6 were synthesized by oxidative cyclization of thienopyrimidinonyl hydrazones using iodobenzene diacetate.
Bicyclic pyridine and pyrimidine p38 kinase inhibitors
-
Page/Page column 18, (2010/01/31)
The present invention discloses compounds corresponding to formula wherein A, R, X, Y, R, R1 and R2 are as defined above, pharmaceutical formulations, methods of making and uses thereof.
